Loading company…
Shanghai biopharmaceutical company developing monoclonal antibody drugs and antibody discovery platforms.
Based in Shanghai, China and founded in 2015, Sanyou Biopharmaceuticals Co., Ltd. develops innovative monoclonal antibody drugs and offers therapeutic antibody discovery and related technology platforms. It has filed over 130 invention patents and has business centers across Asia, North America and Europe. In February 2026, returning investor Shanghai ZJ Bio-Tech Co., Ltd. and new investor Yanghe Biomedicine Industry Investment partly acquired the company from Haier Capital. Its revenue comes from providing integrated antibody drug development platforms.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in